- Home
- ESE vs SRRK Comparison
ESE vs SRRK Comparison
Compare ESE & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESE | SRRK |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ESE | SRRK |
|---|---|---|
| Price | $211.71 | $46.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $237.50 | $49.80 |
| AVG Volume (30 Days) | 184.6K | ★ 1.1M |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | ★ 193.06 | N/A |
| EPS | ★ 11.55 | N/A |
| Revenue | ★ $1,095,388,000.00 | N/A |
| Revenue This Year | $18.95 | N/A |
| Revenue Next Year | $6.83 | $20,271.77 |
| P/E Ratio | $18.54 | ★ N/A |
| Revenue Growth | ★ 19.18 | N/A |
| 52 Week Low | $127.23 | $22.71 |
| 52 Week High | $229.46 | $48.28 |
Technical Indicators
Market Signals| Indicator | ESE | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 59.97 |
| Support Level | $197.61 | $40.63 |
| Resistance Level | $217.37 | $44.50 |
| Average True Range (ATR) | 4.93 | 2.09 |
| MACD | 1.95 | -0.14 |
| Stochastic Oscillator | 77.10 | 93.21 |
Price Performance
Historical ComparisonAbout ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.